DK429780A - 1,2,4-oxadiazolin-5-on-derivater eller syreadditionssalte eller kvaternaere salte deraf og deres fremstilling - Google Patents

1,2,4-oxadiazolin-5-on-derivater eller syreadditionssalte eller kvaternaere salte deraf og deres fremstilling

Info

Publication number
DK429780A
DK429780A DK429780A DK429780A DK429780A DK 429780 A DK429780 A DK 429780A DK 429780 A DK429780 A DK 429780A DK 429780 A DK429780 A DK 429780A DK 429780 A DK429780 A DK 429780A
Authority
DK
Denmark
Prior art keywords
salts
oxadiazoline
derivatives
preparation
acid additional
Prior art date
Application number
DK429780A
Other languages
English (en)
Other versions
DK149854B (da
DK149854C (da
Inventor
K Takacs
I Kiss
A Simay
P Literati
M Hetyey
M Ecsery
L Szekeres
G Papp
S Viragh
E Udvardy
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DK429780A publication Critical patent/DK429780A/da
Publication of DK149854B publication Critical patent/DK149854B/da
Application granted granted Critical
Publication of DK149854C publication Critical patent/DK149854C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/475Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • C07D273/02Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having two nitrogen atoms and only one oxygen atom
    • C07D273/04Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK429780A 1979-10-11 1980-10-10 Analogifremgangsmaade til fremstilling af 1,2,4-oxadiazolin-5-oner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf samt mellemprodukter til anvendelse ved fremstillingen DK149854C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUCI001973 1979-10-11
HU79CI1973A HU179951B (en) 1979-10-11 1979-10-11 Process for preparing 1,2,4-oxadiazolin-5-one derivatives and pharmaceutical compositions containing thereof

Publications (3)

Publication Number Publication Date
DK429780A true DK429780A (da) 1981-04-12
DK149854B DK149854B (da) 1986-10-13
DK149854C DK149854C (da) 1987-04-21

Family

ID=10994764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK429780A DK149854C (da) 1979-10-11 1980-10-10 Analogifremgangsmaade til fremstilling af 1,2,4-oxadiazolin-5-oner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf samt mellemprodukter til anvendelse ved fremstillingen

Country Status (23)

Country Link
US (1) US4365064A (da)
JP (1) JPS5661375A (da)
AT (1) AT375369B (da)
BE (1) BE885633A (da)
CA (1) CA1154019A (da)
CH (1) CH649547A5 (da)
CS (1) CS241032B2 (da)
DD (1) DD153550A5 (da)
DE (1) DE3037432A1 (da)
DK (1) DK149854C (da)
ES (1) ES8106725A1 (da)
FI (2) FI71318C (da)
FR (1) FR2467203A1 (da)
GB (1) GB2059967B (da)
HU (1) HU179951B (da)
IL (1) IL61175A (da)
IT (1) IT1129305B (da)
NL (1) NL8005586A (da)
NO (1) NO154795C (da)
PL (3) PL132131B1 (da)
SE (1) SE452158B (da)
SU (1) SU1087519A1 (da)
YU (1) YU41738B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives
ATE265998T1 (de) * 2000-03-20 2004-05-15 N Gene Res Lab Inc Propancarbonsäure-amidoxim derivate, ein verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die diese entahlten
CA2894126A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
US9604930B2 (en) 2012-12-21 2017-03-28 Epizyme, Inc. Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
US8940726B2 (en) 2012-12-21 2015-01-27 Epizyme, Inc. PRMT5 inhibitors and uses thereof
CA2894157A1 (en) 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
WO2014100716A1 (en) * 2012-12-21 2014-06-26 Epizyme, Inc. Prmt5 inhibitors and uses thereof
AU2015301196A1 (en) 2014-08-04 2017-01-12 Epizyme, Inc. PRMT5 inhibitors and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1529700A (fr) * 1967-04-11 1968-06-21 Dausse Sa Lab Tertioaminoalcoyl oxadiazolinones et leur procédé de préparation
FR1575552A (da) * 1967-12-07 1969-07-25
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
US3994891A (en) * 1974-12-20 1976-11-30 Armour Pharmaceutical Company Tetrahydroisoquinoline compounds
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
HU180708B (en) * 1979-10-11 1983-04-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 1,2,4-oxadiazine derivatives

Also Published As

Publication number Publication date
IT8068555A0 (it) 1980-10-09
GB2059967A (en) 1981-04-29
ATA501380A (de) 1983-12-15
ES495819A0 (es) 1981-09-16
FI803219L (fi) 1981-04-12
FI803220L (fi) 1981-04-12
FI71318B (fi) 1986-09-09
PL131451B1 (en) 1984-11-30
JPS5661375A (en) 1981-05-26
GB2059967B (en) 1983-06-02
ES8106725A1 (es) 1981-09-16
PL227209A1 (da) 1981-12-11
SE8007025L (sv) 1981-04-12
FI71932B (fi) 1986-11-28
IL61175A (en) 1984-08-31
SE452158B (sv) 1987-11-16
IL61175A0 (en) 1980-11-30
CS673780A2 (en) 1985-06-13
CH649547A5 (de) 1985-05-31
SU1087519A1 (ru) 1984-04-23
IT1129305B (it) 1986-06-04
DK149854B (da) 1986-10-13
FR2467203B1 (da) 1985-03-22
DE3037432A1 (de) 1981-05-27
YU41738B (en) 1987-12-31
US4365064A (en) 1982-12-21
BE885633A (fr) 1981-02-02
NO154795C (no) 1986-12-29
PL131375B1 (en) 1984-11-30
PL232292A1 (da) 1982-04-26
CA1154019A (en) 1983-09-20
AT375369B (de) 1984-07-25
CS241032B2 (en) 1986-03-13
YU259480A (en) 1984-02-29
FI71932C (fi) 1987-03-09
NL8005586A (nl) 1981-04-14
DK149854C (da) 1987-04-21
NO154795B (no) 1986-09-15
HU179951B (en) 1983-01-28
PL232293A1 (da) 1982-04-26
FI71318C (fi) 1986-12-19
PL132131B1 (en) 1985-02-28
FR2467203A1 (fr) 1981-04-17
DD153550A5 (de) 1982-01-13
NO803044L (no) 1981-04-13

Similar Documents

Publication Publication Date Title
DK23981A (da) Agmatinderivater og salte deraf deres fremstilling og anvendelse
DK158659C (da) 2,4,6-triiod-isophthalsyrederivater, deres fremstilling og roentgenkontrastmidler indeholdende disse.
DK513480A (da) N-adamantansubstituerede tetrapeptidamider eller farmakologisk acceptable salte deraf og fremgangsmaade til deres fremstilling
DK61887A (da) Substituerede 5-amino-4-hydroxy-valerylderivater og salte deraf samt deres fremstilling og anvendelse
DK217787A (da) Substituerede 2,4-diamino-5-cyano-pyrimidiner og salte deraf samt deres fremstilling og anvendelse
DK404180A (da) Polyetherpolyaminer og salte deraf deres fremstilling og anvendelse
DK323981A (da) 4,5-diaryl-alfa-polyfluoralkyl-1h-imidazol-2-methanaminer eller syreadditionssalte deraf deres fremstilling og anvendelse som antiinflammatoriske midler
DK567983D0 (da) 2-hydroxymethyl-3-carbamoyl-1,4-dihydro-pyridin-forbindelser og salte deraf samt deres fremstilling og anvendelse
DK192788D0 (da) Substituerede anilidderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK429780A (da) 1,2,4-oxadiazolin-5-on-derivater eller syreadditionssalte eller kvaternaere salte deraf og deres fremstilling
DK504680A (da) 4,5-umaettede 16-hydroxyprostansyrederivater og deres fremstilling samt mellemprodukter hertil og disses fremstilling
DK38587A (da) Mono- og disaccharidylderivater og salte deraf samt deres fremstilling og anvendelse
DK43679A (da) 4-(cycloalkyl-eller cycloalkenyl-substitueret) amino-,alkylamino-eller alkenylaminobenzoesyrer samt salte og derivater deraf samt deres fremstilling og anvendelse
DK162882A (da) Imidazolderivater eller syreadditionssalte deraf,deres fremstilling og anvendelse
DK194280A (da) Bis-(4-dimethoxydaunorubicin)-dihydrazoner eller salte deraf samt deres fremstilling
DK429680A (da) 1,2,4-oxadiazinderivater eller syreadditionssalte eller kvaternaere salte deraf deres fremstilling og anvendelse
DK154586A (da) Alkanoylanilider eller salte deraf, deres fremstilling og anvendelse som insekticider og arachmicider
DK256484A (da) Aryloxycycloalkanolaminoalkylenarylketoner eller salte deraf, deres fremstilling og mellemprodukter hertil
DK300583D0 (da) Racemiske eller optisk aktive eburnanoximderivater eller syreadditionssalte deraf, deres fremstilling og anvendelse
DK440880A (da) Benzimidazolderivater eller salte deraf og fremgangsmaade til deres fr&mstilling
DK325687D0 (da) Hydrogenerede 1-phenoxyalkylpyridin-3-carboxylsyreforbindelser og salte deraf samt deres fremstilling og anvendelse
DK204780A (da) 3-substituerede hexahydropyrimido (1,2-a) azepiner eller salte deraf deres fremstilling og anvendelse
DK494282A (da) Cycliske iminderivater eller salte deraf, deres fremstilling og anvendelse som antiarytmiske midler
DK368483A (da) Imidazolderivater eller salte deraf, fremgangsmaade til deres fremstilling samt deres anvendelse
DK254983D0 (da) 4-aryl-2-methyl-1,2,3,4-tetrahydroisoquinolinderivater eller syreadditionssalte deraf og fremgangsmade til deres fremstilling

Legal Events

Date Code Title Description
PBP Patent lapsed